He Q et al. |
Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver. |
2006 |
Toxicol. Sci. |
pmid:16960033
|
Voss KA et al. |
Reproductive and sphingolipid metabolic effects of fumonisin B(1) and its alkaline hydrolysis product in LM/Bc mice: hydrolyzed fumonisin B(1) did not cause neural tube defects. |
2009 |
Toxicol. Sci. |
pmid:19783636
|
Ferrante MC et al. |
Effect of fumonisin B1 on structure and function of macrophage plasma membrane. |
2002 |
Toxicol. Lett. |
pmid:11888701
|
Bondy GS et al. |
Retrospective evaluation of serum ornithine carbamyltransferase activity as an index of hepatotoxicity in toxicological studies with rats. |
2000 |
Toxicol. Lett. |
pmid:10713481
|
Raynal M et al. |
Effects of fumonisin B1 present in Fusarium moniliforme culture material on drug metabolising enzyme activities in ducks. |
2001 |
Toxicol. Lett. |
pmid:11369472
|
Wan LY et al. |
Individual and combined effects of Fusarium toxins on the mRNA expression of pro-inflammatory cytokines in swine jejunal epithelial cells. |
2013 |
Toxicol. Lett. |
pmid:23688591
|
Steyn PS |
Mycotoxins, general view, chemistry and structure. |
1995 |
Toxicol. Lett. |
pmid:8597152
|
Kuiper-Goodman T |
Mycotoxins: risk assessment and legislation. |
1995 |
Toxicol. Lett. |
pmid:8597153
|
Clarke R et al. |
High content analysis: a sensitive tool to detect and quantify the cytotoxic, synergistic and antagonistic effects of chemical contaminants in foods. |
2015 |
Toxicol. Lett. |
pmid:25623391
|
Chuturgoon AA et al. |
Fumonisin Bâ‚ modulates expression of human cytochrome P450 1b1 in human hepatoma (Hepg2) cells by repressing Mir-27b. |
2014 |
Toxicol. Lett. |
pmid:24614526
|
Fernández-Blanco C et al. |
An in vitro investigation on the cytotoxic and nuclear receptor transcriptional activity of the mycotoxins fumonisin B1 and beauvericin. |
2016 |
Toxicol. Lett. |
pmid:27234500
|
Chuturgoon AA et al. |
Fumonisin Bâ‚ inhibits apoptosis in HepG2 cells by inducing Birc-8/ILP-2. |
2015 |
Toxicol. Lett. |
pmid:25800559
|
He Q et al. |
Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition. |
2001 |
Toxicol. Appl. Pharmacol. |
pmid:11437650
|
Ramasamy S et al. |
Fumonisin B1 alters sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture. |
1995 |
Toxicol. Appl. Pharmacol. |
pmid:7645031
|
Cai Q et al. |
Validation of fumonisin biomarkers in F344 rats. |
2007 |
Toxicol. Appl. Pharmacol. |
pmid:17904604
|
Constable PD et al. |
Ingestion of fumonisin B1-containing culture material decreases cardiac contractility and mechanical efficiency in swine. |
2000 |
Toxicol. Appl. Pharmacol. |
pmid:10652243
|
Suzuki CA et al. |
The effects of fumonisin B1 on several markers of nephrotoxicity in rats. |
1995 |
Toxicol. Appl. Pharmacol. |
pmid:7645015
|
Carlson DB et al. |
Fumonisin B1 promotes aflatoxin B1 and N-methyl-N'-nitro-nitrosoguanidine-initiated liver tumors in rainbow trout. |
2001 |
Toxicol. Appl. Pharmacol. |
pmid:11264020
|
Yoo HS et al. |
Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity. |
1996 |
Toxicol. Appl. Pharmacol. |
pmid:8658522
|
Kim MS et al. |
Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway. |
2001 |
Toxicol. Appl. Pharmacol. |
pmid:11601888
|